Showing results (151-160 of 486) with videos related to
Sort By:
Pageof 49
The Lancet. Oncology|September 6, 2017
Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension studyUwe Platzbecker, Ulrich Germing, Katharina S Götze, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 16, 2016
Increased EPO Levels Are Associated With Bone Loss in Mice Lacking PHD2 in EPO-Producing CellsMartina Rauner, Kristin Franke, Marta Murray, et al.American Journal of Hematology|January 19, 2026
Impact of Mutational Landscape and Burden on RBC Transfusion Response in Patients With Lower-Risk Myelodysplastic Syndromes (LR-MDS) in the COMMANDS StudyRami S Komrokji, Sheida Hayati, Manuel Ugidos, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 14, 2011
WNT5A is induced by inflammatory mediators in bone marrow stromal cells and regulates cytokine and chemokine productionMartina Rauner, Nicola Stein, Maria Winzer, et al.Haematologica|May 28, 2026
Next generation sequencing-based measurable residual disease detection predicts outcomes in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantationSimon M Krauß, Tara Holloway, Anne Weigert, et al.American Journal of Hematology|July 25, 2003
Imatinib in Philadelphia chromosome-positive chronic phase CML patients: molecular and cytogenetic response rates and prediction of clinical outcomePhilipp Le Coutre, Karl-Anton Kreuzer, Il-Kang Na, et al.Haematologica|May 30, 2013
Mesenchymal stromal cells from patients with myelodyplastic syndrome display distinct functional alterations that are modulated by lenalidomideRuben A Ferrer, Manja Wobus, Catrin List, et al.Annals of Hematology|November 20, 2017
Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study GroupThomas Schroeder, Christina Rautenberg, William Krüger, et al.Frontiers in Neurology|June 9, 2023
Case report: Treatment of advanced CSF1-receptor associated leukoencephalopathy with hematopoietic stem cell transplantCaroline G Bergner, Lisa Schäfer, Vladan Vucinic, et al.The Lancet. Haematology|December 25, 2017
Momelotinib versus best available therapy in patients with myelofibrosis previously treated with ruxolitinib (SIMPLIFY 2): a randomised, open-label, phase 3 trialClaire N Harrison, Alessandro M Vannucchi, Uwe Platzbecker, et al.Pageof 49